Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mark Reinhard1,2, Jonas Eiberg3,4,5

  • 1Blodtryksklinikken, Nyresygdomme, Aarhus Universitetshospital.

Ugeskrift for Laeger
|September 29, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aortic Calcification and Pulse Wave Velocity Remain Associated after Adjustment for Kidney Function and Covariates.

Pulse (Basel, Switzerland)·2026
Same author

Thoracoscopic Sympathectomy in Treatment-Resistant Essential Hypertension: A Novel Approach to Reduce Sympathetic Activity and Blood Pressure.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same author

Rivaroxaban Does Not Alter Carotid Plaque Echolucency, Volume, or Neovascularisation.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2025
Same author

Pre-admission Opioid Use and Associated Outcomes in Patients Revascularised for Lower Peripheral Artery Disease.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2025
Same author

[Acute limb ischaemia].

Ugeskrift for laeger·2025
Same author

PIVKA-II but not dp-ucMGP is associated with aortic calcification in chronic kidney disease.

BMC nephrology·2024
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Renal artery stenting may benefit high-risk patients with atherosclerotic renovascular disease. A new Danish trial investigates if stenting improves outcomes compared to medical therapy alone for these patients.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Interventional Cardiology

Background:

  • Atherosclerotic renovascular disease (ARVD) poses a high cardiovascular risk.
  • Previous trials show renal artery stenting offers limited benefit over medical therapy in general ARVD populations.
  • High-risk ARVD patients with specific clinical syndromes were often excluded from prior studies.

Approach:

  • Review of existing literature on ARVD and renal artery stenting.
  • Analysis of recent cohort studies suggesting potential benefits in high-risk ARVD patients.
  • Initiation of a Danish randomized trial to further investigate these findings in a targeted population.

Key Points:

  • Renal artery stenting has not consistently outperformed medical therapy in broad ARVD trials.

Related Experiment Videos

  • Emerging cohort data indicate potential benefits of stenting for blood pressure and kidney function in select high-risk ARVD patients.
  • A new randomized trial aims to rigorously assess the efficacy of stenting in this specific high-risk group.

    • Conclusions:

    • The role of renal artery stenting in ARVD requires further clarification, particularly for high-risk individuals.
    • Ongoing research, including the Danish trial, is crucial for defining optimal treatment strategies for atherosclerotic renal artery stenosis.
    • Evidence suggests a potential niche for intervention in carefully selected high-risk ARVD patients.